期刊文献+

脓毒症患者血小板计数及体积变化趋势的临床意义 被引量:1

Change trend and clinical significance of platelet count and mean platelet volume in septic patients
原文传递
导出
摘要 目的观察脓毒症患者血小板计数(PC)、血小板体积(MPV)的变化趋势,探讨两者相关性及其临床意义。方法应用HEMACELL Plus全自动22项5类血细胞分析仪,通过阻抗法检测40例脓毒症患者发病后1 d、3 d、7 d、10 d的PC、MPV,并回顾性将脓毒症患者分为死亡组和存活组,分析其PC、MPV变化趋势,并进行两者相关性分析。结果①入院时存活组和死亡组患者PC均低于正常生理范围,死亡组PC在各时相点均低于存活组(1 d、3 d P>0.05,7 d、10 d P<0.01)。存活组血小板在入ICU第3天明显下降(P<0.01),继之于第7天、10天持续上升(P均<0.01)。死亡组PC则呈持续下降趋势(P均<0.01)。②入院时存活组和死亡组患者MPV均基本上处于正常生理范围,但是死亡组MPV值比存活组患者高(P均<0.05),病程中存活组患者MPV呈进行性下降趋势,而死亡组患者MPV呈进行性上升趋势(P均<0.01)。③PC与MPV呈显著负相关。结论PC、MPV的变化可能成为脓毒症患者血小板生成和活性紊乱以及骨髓反应的间接标志,常规检测脓毒症患者的PC、MPV变化趋势,尤其早期检测MPV,可能成为评价脓毒症病情及骨髓反应情况的一种快速、可信的手段。 Objective To investigate the change trend and clinical significance of platelet count (PC) and mean platelet volume (MPV) in septic patients. Methods PC and MPV were measured with HEMACELL Plus at 1st, 3rd, 7th and 10th day of sepsis in 40 patients. The septic patients were divided into survivor group and non - survivor group according to the final outcomes. The change trend of PC and MPV and their relationship was analysed. Results PC was slightly lower than normal range immediately after admission in both groups, continuously decreased in the following days (at 7 th and 10 th day, P 〈 0.01 ) in non -survivor group, and decreased first (at 3rd day, P 〈 0.01 ) and then increased (at 7th and 10th day, P 〈 0.01 ) in survivor group. MPV progressively augmented in non - survivor group and gradually minished in survivor group ( compared between groups, P 〈 0.05 ). PC was significantly and negatively correlated with MPV. Conclusion The changes of PC and MPV may be an indirect sign of disturbance in platelet production and activity and bone marrow response in septic patients. The routine measurement of PC and MPV, especially MPV in the early stage, may be considered as a quick and reliable method to assess the state of sepsis and bone marrow response.
出处 《国际麻醉学与复苏杂志》 CAS 2007年第5期393-395,共3页 International Journal of Anesthesiology and Resuscitation
关键词 脓毒症 血小板计数(PC) 血小板(MPV) sepsis platelet count mean platelet volume
  • 相关文献

参考文献12

  • 1Strauss R, Wehler M, Mehler K, et al. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med, 2002,30: 1765-1771.
  • 2王洪霞,刘健,马树林,闫素英.血小板水平在危重病临床监测中的意义[J].中国危重病急救医学,2006,18(4):251-251. 被引量:13
  • 3Levy MM,Fink MP,Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Intensive Care Med, 2003,29:530-538.
  • 4王红,张淑文,任爱民,张丽霞,王超,黄樱,苏艳丽,王宝恩.重度脓毒症凝血功能紊乱与病情严重度及预后的关系[J].中华急诊医学杂志,2005,14(10):804-806. 被引量:54
  • 5Van der schueren S, De Weerdt A ,Malbrain M , et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med, 2000, 28:1871- 1876.
  • 6Akca S, Haji-Michael P, de Mendonca A , et al. Time course of platelet counts in critically ill patients. Crit Care Med, 2002, 30: 753-756.
  • 7谢杨卿,唐锁勤,谭汉君,刘风英.小儿急性淋巴细胞白血病血小板计数与平均血小板容积的改变及其临床意义[J].临床血液学杂志,1992,5(4):172-173. 被引量:10
  • 8Van der Lelie J, Von dem Borne AK. J Increased mean platelet volume in septicaemia. Clin Pathol, 1983,36:693-696.
  • 9Dastugue N, Picheloup F, Sie P, et al. Increase in mean platelet volume in shock-related thrombocytopenia. Nour Presse Med, 1982,11: 2899-2901.
  • 10Taniguchi T, Takagi D, Takeyama N, et al. Platelet size and function in septic rats: Changes in the adenylate pool. Surg Res, 1990, 49: 400-407.

二级参考文献17

  • 1American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med,1992, 20 (6): 864- 874.
  • 2Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med, 1995, 23 (10): 1638- 1652.
  • 3Mammen EF. Disseminated intravascular coagulation (DIC). Clin Lab Sci, 2000, 13 (4): 239- 245.
  • 4Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992, 101(6): 1644- 1655.
  • 5ten Cate H, Timmerman JJ, Levi M. The pathophysiology of disseminated intravascular coagulation. Thromb Haemost, 1999, 82 (2): 713-717.
  • 6Brun - Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors,and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA, 1995, 274 (12): 968-974.
  • 7Kinasewitz GT, Yan SB, Basson B, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro - organism. Crit Care Med, 2004 ,8(2):82-90.
  • 8Levi M, de Jonge E, van der Poll T, et al. Novel approaches to the management of disseminated intravascular coagulation. Crit Care Med,2000, 28 (9 Suppl): 20-24.
  • 9Creasey AA, Chang AC, Feigen L, et al. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest, 1993, 91 (6): 2850-2860.
  • 10Coughlin SR. Thrombin signalling and protease - activated receptors.Nature, 2000, 407 (6801): 258 - 2864. 12 Paw linshi R,Mackman N. Tissue factor, coagulation protease, and proteaseactivated receptors in endotoxemia and sepsis. Crit Care Med, 2004,32 (5 suppl): 293 - 297.

共引文献71

同被引文献9

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部